Leramistat, a first-in-class mitochondrial complex I modulator (MCM),[1],[2] improves muscle...
22nd April 2026
Istesso, the company developing the first oral regenerative medicines, today...
2nd March 2026
Image: Ticio encadenado by Gregorio Martínez (1547–1598) Regenerative medicine promises...
6th January 2026
Recent press coverage of our work to develop healthspan-extending drugs recognises their potential to offer “a more sustainable path to healthier, longer lives”
4th December 2025
Advancement of leramistat, a first-in-class mitochondrial complex I modulator (MCM),...
26th November 2025
Istesso’s new class of developmental drugs, which inhibit mitochondrial complex...
17th July 2025
Istesso, the leading adaptive tissue-repair company, is pleased to announce...
4th June 2025
I’ve been thinking about Taylor Swift - not for the usual reasons, but in the context of medical innovation.
10th February 2025
CEO Lisa Patel wants to invite patients to the table and put their everyday experiences of living with chronic diseases at the forefront of future drug development.
16th October 2023